Meeting
2022 ASCO Genitourinary Cancers Symposium
Characterization of aberrant alternative splicing landscape in patients with renal cell carcinoma (RCC).
Authors
Ameish Govindarajan
City of Hope Comprehensive Cancer Center, Duarte, CA
Ameish Govindarajan , Apurva M. Hegde , Neal Shiv Chawla , Nazli Dizman , Zeynep Busra Zengin , Luis A Meza , Ramya Muddasani , Alex Chehrazi-Raffle , Jasnoor Malhotra , Daniela V. Castro , Sabrina Salgia , Cristiane Decat Bergerot , Nishita Tripathi , Nicolas Sayegh , Errol James Philip , Joann Hsu , Sara A. Byron , Patrick Pirrotte , Sumanta K. Pal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 386)
DOI
10.1200/JCO.2022.40.6_suppl.386
Abstract #
386
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world outcomes of patients with operable renal cell carcinoma from the German translational cancer research consortium (DKTK) network.
First Author: Viktor Grünwald
Poster
2022 ASCO Annual Meeting
Renal cell carcinoma in renal transplant recipients: Is there a role for screening?
First Author: Binoy Yohannan
Poster
2020 ASCO Virtual Scientific Program
Clinically advanced renal cell carcinoma (RCC) and renal sarcoma (RSC) in young patients: A comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky
Poster
2020 Genitourinary Cancers Symposium
NF2 mutation-driven renal cell carcinomas (RCC): A comprehensive genomic profiling (CGP) study.
First Author: Evgeny Yakirevich